Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers

CONCLUSIONS: Novel biomarkers might be useful in risk stratification of thromboembolic and bleeding events in AF patients with stage 4 CKD receiving oral anticoagulants.PMID:34392517 | DOI:10.33963/KP.a2021.0088

Source: Kardiologia Polska - August 15, 2021 Category: Cardiology Authors: Pawe ł T Matusik Wiktor J Le śniak Zbigniew Heleniak Anetta Undas Source Type: research